Literature DB >> 27285637

Oseltamivir pharmacokinetics in Mexican obese and non-obese healthy subjects and patients. Evidence for an absence of interethnic variability.

Gilberto Castañeda-Hernández1, Adrián Martínez-Talavera1, Lina Marcela Barranco-Garduño2, Ariadna Cervantes-Nevárez2, Héctor León-Molina2, Miriam Del Carmen Carrasco-Portugal2, Francisco Javier Flores-Murrieta2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27285637      PMCID： PMC5338102          DOI： 10.1111/bcp.13003

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

Authors:  Mohamed A Kamal; Scott A Van Wart; Craig R Rayner; Vishak Subramoney; Daniel K Reynolds; Catharine C Bulik; Patrick F Smith; Sujata M Bhavnani; Paul G Ambrose; Alan Forrest
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

3.  Oseltamivir pharmacokinetics in Mexican obese and non-obese healthy subjects and patients. Evidence for an absence of interethnic variability.

Authors:  Gilberto Castañeda-Hernández; Adrián Martínez-Talavera; Lina Marcela Barranco-Garduño; Ariadna Cervantes-Nevárez; Héctor León-Molina; Miriam Del Carmen Carrasco-Portugal; Francisco Javier Flores-Murrieta
Journal:  Br J Clin Pharmacol       Date:  2016-06-10       Impact factor: 4.335

4.  Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers.

Authors:  Kalayanee Chairat; Podjanee Jittamala; Warunee Hanpithakpong; Nicholas P J Day; Nicholas J White; Sasithon Pukrittayakamee; Joel Tarning
Journal:  Br J Clin Pharmacol       Date:  2016-03-04       Impact factor: 4.335
  4 in total
  1 in total

1.  Oseltamivir pharmacokinetics in Mexican obese and non-obese healthy subjects and patients. Evidence for an absence of interethnic variability.

Authors:  Gilberto Castañeda-Hernández; Adrián Martínez-Talavera; Lina Marcela Barranco-Garduño; Ariadna Cervantes-Nevárez; Héctor León-Molina; Miriam Del Carmen Carrasco-Portugal; Francisco Javier Flores-Murrieta
Journal:  Br J Clin Pharmacol       Date:  2016-06-10       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.